Wang AJ - Search Results

1

CNIH4 governs cervical cancer progression through reducing ferroptosis.

Yang JY, Ke D, Li Y, Shi J, Wan SM, Wang AJ, Zhao MN, Gao H. Yang JY, et al. Among authors: wang aj. Chem Biol Interact. 2023 Oct 1;384:110712. doi: 10.1016/j.cbi.2023.110712. Epub 2023 Sep 15. Chem Biol Interact. 2023. PMID: 37716418

2

Signatures of tumor-associated macrophages correlate with treatment response in ovarian cancer patients.

Gao Y, Qi Y, Shen Y, Zhang Y, Wang D, Su M, Liu X, Wang A, Zhang W, He C, Yang J, Dai M, Wang H, Cai H. Gao Y, et al. Aging (Albany NY). 2024 Jan 3;16(1):207-225. doi: 10.18632/aging.205362. Epub 2024 Jan 3. Aging (Albany NY). 2024. PMID: 38175687 Free PMC article.

3

Long non-coding RNA NEAT1 promotes aerobic glycolysis and progression of cervical cancer through WNT/β-catenin/PDK1 axis.

Su M, Liang Z, Shan S, Gao Y, He L, Liu X, Wang A, Wang H, Cai H. Su M, et al. Cancer Med. 2024 May;13(9):e7221. doi: 10.1002/cam4.7221. Cancer Med. 2024. PMID: 38733179 Free PMC article.

4

Stapled peptide PROTAC induced significantly greater anti-PD-L1 effects than inhibitor in human cervical cancer cells.

Shi YY, Wang AJ, Liu XL, Dai MY, Cai HB. Shi YY, et al. Among authors: wang aj. Front Immunol. 2023 May 30;14:1193222. doi: 10.3389/fimmu.2023.1193222. eCollection 2023. Front Immunol. 2023. PMID: 37325638 Free PMC article.

5

MicroRNA-29a inhibits cell proliferation and arrests cell cycle by modulating p16 methylation in cervical cancer.

Wang A, Xu Q, Sha R, Bao T, Xi X, Guo G. Wang A, et al. Oncol Lett. 2021 Apr;21(4):272. doi: 10.3892/ol.2021.12533. Epub 2021 Feb 9. Oncol Lett. 2021. PMID: 33717269 Free PMC article.

6

A review of recent advances on single use of antibody-drug conjugates or combination with tumor immunology therapy for gynecologic cancer.

Wang AJ, Gao Y, Shi YY, Dai MY, Cai HB. Wang AJ, et al. Front Pharmacol. 2022 Dec 22;13:1093666. doi: 10.3389/fphar.2022.1093666. eCollection 2022. Front Pharmacol. 2022. PMID: 36618922 Free PMC article. Review.

7

PROTACs in Epigenetic Cancer Therapy: Current Status and Future Opportunities.

Liu X, Wang A, Shi Y, Dai M, Liu M, Cai HB. Liu X, et al. Molecules. 2023 Jan 26;28(3):1217. doi: 10.3390/molecules28031217. Molecules. 2023. PMID: 36770884 Free PMC article. Review.

8

Natural killer cell-related anti-tumour adoptive cell immunotherapy.

Qi Y, Li Y, Wang H, Wang A, Liu X, Liang Z, Gao Y, Wei L. Qi Y, et al. J Cell Mol Med. 2024 Jun;28(11):e18362. doi: 10.1111/jcmm.18362. J Cell Mol Med. 2024. PMID: 38837666 Free PMC article. Review.

9

High-potency PD-1/PD-L1 degradation induced by Peptide-PROTAC in human cancer cells.

Dai MY, Shi YY, Wang AJ, Liu XL, Liu M, Cai HB. Dai MY, et al. Among authors: wang aj. Cell Death Dis. 2022 Nov 4;13(11):924. doi: 10.1038/s41419-022-05375-7. Cell Death Dis. 2022. PMID: 36333311 Free PMC article. No abstract available.

10

N6-methyladenosine methyltransferase KIAA1429 promoted ovarian cancer aerobic glycolysis and progression through enhancing ENO1 expression.

Gan L, Zhao S, Gao Y, Qi Y, Su M, Wang A, Cai H. Gan L, et al. Biol Direct. 2023 Oct 9;18(1):64. doi: 10.1186/s13062-023-00420-7. Biol Direct. 2023. PMID: 37807062 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

564 results

Search Page

Filters